Vantage Consulting Group Inc Cytokinetics Inc Transaction History
Vantage Consulting Group Inc
- $7.71 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
410Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$756 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$606 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$499 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$400 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$333 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.85B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...